These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29694626)

  • 1. Association of different biomarkers of renal function with D-dimer levels in patients with type 1 diabetes mellitus (renal biomarkers and D-dimer in diabetes).
    Domingueti CP; Fóscolo RB; Dusse LMS; Reis JS; Carvalho MDG; Gomes KB; Fernandes AP
    Arch Endocrinol Metab; 2018 Feb; 62(1):27-33. PubMed ID: 29694626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
    Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
    J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis.
    Avinash S; Singh VP; Agarwal AK; Chatterjee S; Araya V
    J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients.
    Domingueti CP; Fóscolo RB; Simões E Silva AC; Dusse LM; Reis JS; Carvalho Md; Fernandes AP; Gomes KB
    Arch Endocrinol Metab; 2016 Apr; 60(2):108-16. PubMed ID: 27191046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-Dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus.
    Domingueti CP; Fuzatto JA; Fóscolo RB; Reis JS; Dusse LM; Carvalho MDG; Gomes KB; Fernandes AP
    Clin Chim Acta; 2016 Aug; 459():1-4. PubMed ID: 27208743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Performance of Equations for Estimated Glomerular Filtration Rate in Chinese Patients with Biopsy-Proven Diabetic Nephropathy.
    Wang Y; Zhang J; Teng G; Wu Y; Han Q; Li H; Wang T; Liu F
    Dis Markers; 2019; 2019():4354061. PubMed ID: 31636737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cystatin C- and creatinine-based estimation of glomerular filtration rate according to glycaemic status in Type 2 diabetes.
    Oh SJ; Lee JI; Ha WC; Jeong SH; Yim HW; Son HS; Sohn TS
    Diabet Med; 2012 Jul; 29(7):e121-5. PubMed ID: 22414167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C is Better than Serum Creatinine for Estimating Glomerular Filtration Rate to Detect Osteopenia in Chronic Kidney Disease Patients.
    Kwon YE; Lee MJ; Park KS; Han SH; Yoo TH; Oh KH; Lee J; Lee KB; Chung W; Kim YH; Ahn C; Choi KH
    Yonsei Med J; 2017 Mar; 58(2):380-387. PubMed ID: 28120569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease.
    Bevc S; Hojs R; Ekart R; Završnik M; Gorenjak M; Puklavec L
    Exp Diabetes Res; 2012; 2012():179849. PubMed ID: 23008697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes.
    Cherney DZ; Sochett EB; Dekker MG; Perkins BA
    Diabet Med; 2010 Dec; 27(12):1358-65. PubMed ID: 21059087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes.
    Szopa M; Kapusta M; Matejko B; Klupa T; Koblik T; Kiec-Wilk B; Borowiec M; Malecki MT
    J Diabetes Res; 2015; 2015():183094. PubMed ID: 26347889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults.
    Tsaryk I; Pashkovska N
    J Med Life; 2022 Jun; 15(6):792-796. PubMed ID: 35928354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatinine or cystatin C - which is a better index of renal function in morbid obesity?
    Mysliwiec P; Jasiewicz P; Hady HR; Choromanska B; Mroczko B; Mysliwiec H; Siemiatkowski A; Dadan J; Szmitkowski M
    Adv Med Sci; 2013; 58(2):376-81. PubMed ID: 24421217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cystatin C levels are associated with asymptomatic peripheral arterial disease in type 2 diabetes mellitus patients without overt nephropathy.
    Huh JH; Choi E; Lim JS; Lee MY; Chung CH; Shin JY
    Diabetes Res Clin Pract; 2015 May; 108(2):258-64. PubMed ID: 25743114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    He J; Shlipak M; Anderson A; Roy JA; Feldman HI; Kallem RR; Kanthety R; Kusek JW; Ojo A; Rahman M; Ricardo AC; Soliman EZ; Wolf M; Zhang X; Raj D; Hamm L;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy.
    Pavkov ME; Knowler WC; Hanson RL; Williams DE; Lemley KV; Myers BD; Nelson RG
    Am J Kidney Dis; 2013 Jul; 62(1):33-41. PubMed ID: 23347458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing validity of serum cystatin C for predicting metabolic syndrome.
    Asefy Z; Mirinejad M; Amirrasooli H; Tagikhani M
    Pak J Biol Sci; 2014 Apr; 17(4):582-5. PubMed ID: 25911852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.